Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome
- PMID: 31920009
- PMCID: PMC7034496
- DOI: 10.1002/acn3.50979
Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome
Abstract
Aicardi-Goutières syndrome (AGS) is a rare and likely underdiagnosed genetic leukoencephalopathy, typically presenting in infancy with encephalopathy and characteristic neuroimaging features, with residual static neurological deficits. We describe a patient who, following an initial presentation at the age of 12 months in keeping with AGS, exhibited a highly atypical relapsing course of neurological symptoms in adulthood with essentially normal neuroimaging. Whole-exome sequencing confirmed a pathogenic RNASEH2B gene variant consistent with AGS. This case highlights the expanding phenotypes associated with AGS and the potential role of whole-exome sequencing in facilitating an increase in the rate of diagnosis.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
The c.529G>A (p.Ala177Thr) RNASEH2B Gene Pathogenic Variant as a First-Line Genetic Test for Aicardi-Goutières Syndrome: A Case Series of Four Moroccan Families.Am J Med Genet A. 2025 Jun;197(6):e63997. doi: 10.1002/ajmg.a.63997. Epub 2025 Jan 31. Am J Med Genet A. 2025. PMID: 39890436
-
The Rare Syndrome Aicardi-Goutières 4: A Case Report and Literature Review.Dev Neurobiol. 2025 Apr;85(2):e22965. doi: 10.1002/dneu.22965. Dev Neurobiol. 2025. PMID: 40263931 Free PMC article. Review.
-
p.Arg69Trp in RNASEH2C is a founder variant in three Indian families with Aicardi-Goutières syndrome.Am J Med Genet A. 2018 Jan;176(1):156-160. doi: 10.1002/ajmg.a.38522. Epub 2017 Nov 17. Am J Med Genet A. 2018. PMID: 29150899
-
Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?Dev Med Child Neurol. 2017 Dec;59(12):1307-1311. doi: 10.1111/dmcn.13509. Epub 2017 Aug 1. Dev Med Child Neurol. 2017. PMID: 28762473 Free PMC article.
-
Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.Neuropediatrics. 2016 Dec;47(6):355-360. doi: 10.1055/s-0036-1592307. Epub 2016 Sep 19. Neuropediatrics. 2016. PMID: 27643693 Review.
Cited by
-
Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.Pediatr Rheumatol Online J. 2023 Oct 12;21(1):117. doi: 10.1186/s12969-023-00899-4. Pediatr Rheumatol Online J. 2023. PMID: 37828538 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical